WELL HEALTH TECHNOLOGIES COR (WELL.CA) Fundamental Analysis & Valuation

TSX:WELL • CA94947L1022

Current stock price

4.21 CAD
-0.09 (-2.09%)
Last:

This WELL.CA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

4

1. WELL.CA Profitability Analysis

1.1 Basic Checks

  • In the past year WELL was profitable.
  • WELL had a positive operating cash flow in the past year.
  • The reported net income has been mixed in the past 5 years: WELL reported negative net income in multiple years.
  • Each year in the past 5 years WELL had a positive operating cash flow.
WELL.CA Yearly Net Income VS EBIT VS OCF VS FCFWELL.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M 100M

1.2 Ratios

  • WELL has a Return On Assets of -0.35%. This is comparable to the rest of the industry: WELL outperforms 58.33% of its industry peers.
  • Looking at the Return On Equity, with a value of -0.85%, WELL is in line with its industry, outperforming 58.33% of the companies in the same industry.
  • With a decent Return On Invested Capital value of 4.48%, WELL is doing good in the industry, outperforming 66.67% of the companies in the same industry.
Industry RankSector Rank
ROA -0.35%
ROE -0.85%
ROIC 4.48%
ROA(3y)0.49%
ROA(5y)-0.37%
ROE(3y)0.97%
ROE(5y)-0.81%
ROIC(3y)N/A
ROIC(5y)N/A
WELL.CA Yearly ROA, ROE, ROICWELL.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500 -500 -1K

1.3 Margins

  • WELL has a Operating Margin of 6.62%. This is in the better half of the industry: WELL outperforms 66.67% of its industry peers.
  • WELL's Operating Margin has improved in the last couple of years.
  • WELL's Gross Margin of 44.20% is fine compared to the rest of the industry. WELL outperforms 75.00% of its industry peers.
  • In the last couple of years the Gross Margin of WELL has remained more or less at the same level.
Industry RankSector Rank
OM 6.62%
PM (TTM) N/A
GM 44.2%
OM growth 3Y16.22%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-6.05%
GM growth 5Y0.91%
WELL.CA Yearly Profit, Operating, Gross MarginsWELL.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -500 -1K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. WELL.CA Health Analysis

2.1 Basic Checks

  • WELL has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • The number of shares outstanding for WELL has been increased compared to 1 year ago.
  • WELL has more shares outstanding than it did 5 years ago.
  • The debt/assets ratio for WELL is higher compared to a year ago.
WELL.CA Yearly Shares OutstandingWELL.CA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M 250M
WELL.CA Yearly Total Debt VS Total AssetsWELL.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B

2.2 Solvency

  • WELL has an Altman-Z score of 1.34. This is a bad value and indicates that WELL is not financially healthy and even has some risk of bankruptcy.
  • Looking at the Altman-Z score, with a value of 1.34, WELL is in line with its industry, outperforming 50.00% of the companies in the same industry.
  • WELL has a debt to FCF ratio of 7.56. This is a slightly negative value and a sign of low solvency as WELL would need 7.56 years to pay back of all of its debts.
  • With a Debt to FCF ratio value of 7.56, WELL perfoms like the industry average, outperforming 58.33% of the companies in the same industry.
  • WELL has a Debt/Equity ratio of 0.70. This is a neutral value indicating WELL is somewhat dependend on debt financing.
  • WELL's Debt to Equity ratio of 0.70 is fine compared to the rest of the industry. WELL outperforms 75.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.7
Debt/FCF 7.56
Altman-Z 1.34
ROIC/WACC0.56
WACC8.05%
WELL.CA Yearly LT Debt VS Equity VS FCFWELL.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M 400M 600M 800M

2.3 Liquidity

  • A Current Ratio of 1.03 indicates that WELL should not have too much problems paying its short term obligations.
  • Looking at the Current ratio, with a value of 1.03, WELL is in the better half of the industry, outperforming 75.00% of the companies in the same industry.
  • A Quick Ratio of 1.03 indicates that WELL should not have too much problems paying its short term obligations.
  • With a decent Quick ratio value of 1.03, WELL is doing good in the industry, outperforming 75.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.03
Quick Ratio 1.03
WELL.CA Yearly Current Assets VS Current LiabilitesWELL.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. WELL.CA Growth Analysis

3.1 Past

  • The earnings per share for WELL have decreased strongly by -26.67% in the last year.
  • WELL shows a strong growth in Revenue. In the last year, the Revenue has grown by 52.25%.
  • WELL shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 94.58% yearly.
EPS 1Y (TTM)-26.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%766.67%
Revenue 1Y (TTM)52.25%
Revenue growth 3Y35%
Revenue growth 5Y94.58%
Sales Q2Q%63.9%

3.2 Future

  • WELL is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 40.64% yearly.
  • Based on estimates for the next years, WELL will show a quite strong growth in Revenue. The Revenue will grow by 8.14% on average per year.
EPS Next Y172%
EPS Next 2Y89.9%
EPS Next 3Y40.64%
EPS Next 5YN/A
Revenue Next Year11.69%
Revenue Next 2Y9.2%
Revenue Next 3Y8.14%
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
WELL.CA Yearly Revenue VS EstimatesWELL.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 500M 1B 1.5B
WELL.CA Yearly EPS VS EstimatesWELL.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 0.2 -0.2 0.4

More info and screens

Find the best growth stocksShow best growing peers

6

4. WELL.CA Valuation Analysis

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 38.27 indicates a quite expensive valuation of WELL.
  • Based on the Price/Earnings ratio, WELL is valued a bit cheaper than the industry average as 75.00% of the companies are valued more expensively.
  • Compared to an average S&P500 Price/Earnings ratio of 26.91, WELL is valued a bit more expensive.
  • With a Price/Forward Earnings ratio of 14.07, WELL is valued correctly.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of WELL indicates a rather cheap valuation: WELL is cheaper than 83.33% of the companies listed in the same industry.
  • The average S&P500 Price/Forward Earnings ratio is at 21.99. WELL is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 38.27
Fwd PE 14.07
WELL.CA Price Earnings VS Forward Price EarningsWELL.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 50 100 150

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, WELL is valued cheaper than 91.67% of the companies in the same industry.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of WELL indicates a somewhat cheap valuation: WELL is cheaper than 66.67% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 11.44
EV/EBITDA 8.95
WELL.CA Per share dataWELL.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4

4.3 Compensation for Growth

  • WELL's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • A more expensive valuation may be justified as WELL's earnings are expected to grow with 40.64% in the coming years.
PEG (NY)0.22
PEG (5Y)N/A
EPS Next 2Y89.9%
EPS Next 3Y40.64%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. WELL.CA Dividend Analysis

5.1 Amount

  • WELL does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

WELL.CA Fundamentals: All Metrics, Ratios and Statistics

WELL HEALTH TECHNOLOGIES COR

TSX:WELL (4/28/2026, 7:00:00 PM)

4.21

-0.09 (-2.09%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Industry Strength55.91
Industry Growth90.3
Earnings (Last)03-19
Earnings (Next)05-13
Inst Owners3.71%
Inst Owner ChangeN/A
Ins Owners22.55%
Ins Owner ChangeN/A
Market Cap1.08B
Revenue(TTM)1.40B
Net Income(TTM)-7.36M
Analysts82
Price Target7.21 (71.26%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)27.38%
Min EPS beat(2)-32.99%
Max EPS beat(2)87.74%
EPS beat(4)1
Avg EPS beat(4)-170.63%
Min EPS beat(4)-696.08%
Max EPS beat(4)87.74%
EPS beat(8)3
Avg EPS beat(8)2157.64%
EPS beat(12)3
Avg EPS beat(12)1034.47%
EPS beat(16)4
Avg EPS beat(16)745.25%
Revenue beat(2)0
Avg Revenue beat(2)-2.78%
Min Revenue beat(2)-3.29%
Max Revenue beat(2)-2.26%
Revenue beat(4)1
Avg Revenue beat(4)-1.3%
Min Revenue beat(4)-3.29%
Max Revenue beat(4)1.59%
Revenue beat(8)2
Avg Revenue beat(8)-2.19%
Revenue beat(12)5
Avg Revenue beat(12)-0.86%
Revenue beat(16)8
Avg Revenue beat(16)0%
PT rev (1m)-7.38%
PT rev (3m)-7.61%
EPS NQ rev (1m)-8.16%
EPS NQ rev (3m)-27.42%
EPS NY rev (1m)-29.32%
EPS NY rev (3m)-28.28%
Revenue NQ rev (1m)-0.4%
Revenue NQ rev (3m)-1.05%
Revenue NY rev (1m)0.13%
Revenue NY rev (3m)0.38%
Valuation
Industry RankSector Rank
PE 38.27
Fwd PE 14.07
P/S 0.77
P/FCF 11.44
P/OCF 8.83
P/B 1.25
P/tB N/A
EV/EBITDA 8.95
EPS(TTM)0.11
EY2.61%
EPS(NY)0.3
Fwd EY7.11%
FCF(TTM)0.37
FCFY8.74%
OCF(TTM)0.48
OCFY11.33%
SpS5.48
BVpS3.38
TBVpS-2.68
PEG (NY)0.22
PEG (5Y)N/A
Graham Number2.89212 (-31.3%)
Profitability
Industry RankSector Rank
ROA -0.35%
ROE -0.85%
ROCE 5.33%
ROIC 4.48%
ROICexc 4.85%
ROICexgc 134.73%
OM 6.62%
PM (TTM) N/A
GM 44.2%
FCFM 6.71%
ROA(3y)0.49%
ROA(5y)-0.37%
ROE(3y)0.97%
ROE(5y)-0.81%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y61.44%
ROICexgc growth 5YN/A
ROICexc growth 3Y39.71%
ROICexc growth 5YN/A
OM growth 3Y16.22%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-6.05%
GM growth 5Y0.91%
F-Score5
Asset Turnover0.67
Health
Industry RankSector Rank
Debt/Equity 0.7
Debt/FCF 7.56
Debt/EBITDA 3.22
Cap/Depr 29.72%
Cap/Sales 1.99%
Interest Coverage 3
Cash Conversion 65.37%
Profit Quality N/A
Current Ratio 1.03
Quick Ratio 1.03
Altman-Z 1.34
F-Score5
WACC8.05%
ROIC/WACC0.56
Cap/Depr(3y)21.84%
Cap/Depr(5y)16.82%
Cap/Sales(3y)1.6%
Cap/Sales(5y)1.36%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-26.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%766.67%
EPS Next Y172%
EPS Next 2Y89.9%
EPS Next 3Y40.64%
EPS Next 5YN/A
Revenue 1Y (TTM)52.25%
Revenue growth 3Y35%
Revenue growth 5Y94.58%
Sales Q2Q%63.9%
Revenue Next Year11.69%
Revenue Next 2Y9.2%
Revenue Next 3Y8.14%
Revenue Next 5YN/A
EBIT growth 1Y401.33%
EBIT growth 3Y56.9%
EBIT growth 5YN/A
EBIT Next Year111.26%
EBIT Next 3Y39.56%
EBIT Next 5YN/A
FCF growth 1Y1666.71%
FCF growth 3Y10.25%
FCF growth 5YN/A
OCF growth 1Y1092.06%
OCF growth 3Y16.77%
OCF growth 5YN/A

WELL HEALTH TECHNOLOGIES COR / WELL.CA Fundamental Analysis FAQ

What is the ChartMill fundamental rating of WELL HEALTH TECHNOLOGIES COR (WELL.CA) stock?

ChartMill assigns a fundamental rating of 4 / 10 to WELL.CA.


Can you provide the valuation status for WELL HEALTH TECHNOLOGIES COR?

ChartMill assigns a valuation rating of 6 / 10 to WELL HEALTH TECHNOLOGIES COR (WELL.CA). This can be considered as Fairly Valued.


How profitable is WELL HEALTH TECHNOLOGIES COR (WELL.CA) stock?

WELL HEALTH TECHNOLOGIES COR (WELL.CA) has a profitability rating of 4 / 10.


What is the financial health of WELL HEALTH TECHNOLOGIES COR (WELL.CA) stock?

The financial health rating of WELL HEALTH TECHNOLOGIES COR (WELL.CA) is 3 / 10.